Change in total body water as a predictive tool for growth hormone treatment response

Horm Res Paediatr. 2012;78(1):18-23. doi: 10.1159/000339679. Epub 2012 Jul 18.

Abstract

Background/aims: To investigate whether short-term changes in body composition as a result of growth hormone therapy could be used to predict its growth effect after 1 year in children with growth hormone deficiency (GHD) and children born small for gestational age (SGA).

Methods: 88 GHD children and 99 SGA children who started treatment with recombinant human growth hormone were included. Total body water (TBW) and height were measured. After 1 year, patients were divided into adequate and inadequate responders.

Results: In GHD and SGA children a sensitivity of 87 and 53%, respectively, and a specificity of 58 and 83%, respectively, were found. The positive predictive values for GHD and SGA children were 73 and 90%, respectively. The negative predictive values were 75 and 32%, respectively.

Conclusion: Changes in body composition data measured by TBW are a valuable tool to correctly predict 75% of the GHD children and are only useful in SGA children when the change in TBW is above the cut-off value of 0.7 l/m(2).

Publication types

  • Clinical Trial

MeSH terms

  • Biomarkers, Pharmacological* / analysis
  • Biomarkers, Pharmacological* / metabolism
  • Body Water / drug effects*
  • Body Water / metabolism
  • Body Water / physiology
  • Child
  • Child, Preschool
  • Deuterium
  • Follow-Up Studies
  • Growth Disorders / diagnosis*
  • Growth Disorders / drug therapy*
  • Growth Disorders / metabolism
  • Human Growth Hormone / deficiency
  • Human Growth Hormone / therapeutic use*
  • Humans
  • Infant, Newborn
  • Infant, Small for Gestational Age / growth & development*
  • Infant, Small for Gestational Age / metabolism
  • Predictive Value of Tests
  • Prognosis
  • Treatment Outcome

Substances

  • Biomarkers, Pharmacological
  • Human Growth Hormone
  • Deuterium